The British Business Bank has committed £100 million to London-based Apposite, marking the launch of Apposite Healthcare Growth I and targeting a long-identified funding gap in the UK life sciences sector.
Announced on April 17, 2026, the commitment is intended to help close the UK life sciences scale-up gap, where many companies have access to early-stage backing but face limited options as they move into later growth phases.
Apposite, a healthcare and life sciences investor based in London, said the fund will support UK businesses developing technologies and services across areas including medical products, diagnostics, life sciences tools, digital health and pharmaceutical services. The British Business Bank described the £100 million commitment as its largest to date.
Announced on April 17, 2026, the commitment is intended to help close the UK life sciences scale-up gap, where many companies have access to early-stage backing but face limited options as they move into later growth phases.
Apposite, a healthcare and life sciences investor based in London, said the fund will support UK businesses developing technologies and services across areas including medical products, diagnostics, life sciences tools, digital health and pharmaceutical services. The British Business Bank described the £100 million commitment as its largest to date.